Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.175 USD | -2.00% | +0.48% | +14.84% |
Business Summary
Number of employees: 413
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Therapeutic Products and Devices
100.0
%
| 100 | 100.0 % | 199 | 100.0 % | +99.42% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 100 | 100.0 % | 199 | 100.0 % | +99.42% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 47 | 16-03-13 |
Sanjay Singh
CTO | Chief Tech/Sci/R&D Officer | 57 | 22-09-30 |
Kevin Kaiserman
CTO | Chief Tech/Sci/R&D Officer | - | 20-08-30 |
Joseph Kocinsky
CTO | Chief Tech/Sci/R&D Officer | 60 | 02-12-31 |
Burkhard Blank
CTO | Chief Tech/Sci/R&D Officer | 69 | 23-05-23 |
Lauren Sabella
COO | Chief Operating Officer | 63 | 23-03-26 |
Investor Relations Contact | 63 | 03-05-31 | |
Steven Binder
PRN | Corporate Officer/Principal | 61 | 17-07-16 |
Karen Jaffe
LAW | General Counsel | - | 19-12-31 |
David Thomson
LAW | General Counsel | 57 | 01-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 18-11-26 | |
Anthony Hooper
BRD | Director/Board Member | 69 | 19-12-31 |
Ronald Consiglio
BRD | Director/Board Member | 80 | 03-09-30 |
Kent Kresa
BRD | Director/Board Member | 86 | 04-05-31 |
Michael Friedman
BRD | Director/Board Member | 80 | 03-11-30 |
Jennifer Grancio
BRD | Director/Board Member | 52 | 20-03-22 |
Sabrina Kay
BRD | Director/Board Member | 61 | 20-11-30 |
James Shannon
CHM | Chairman | 67 | 15-05-20 |
Michael Castagna
CEO | Chief Executive Officer | 47 | 16-03-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 270,679,296 | 266,543,127 ( 98.47 %) | 0 | 98.47 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.84% | 1.15B | |
-3.24% | 102B | |
+1.71% | 96.29B | |
+2.13% | 22.18B | |
-15.69% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.64% | 16.36B | |
+5.73% | 13.97B | |
+33.79% | 12.17B |
- Stock Market
- Equities
- MNKD Stock
- Company MannKind Corporation